BioSpace News Archive

Inari Medical, Inc. announced today the enrollment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (“FLASH”) using the FlowTriever® System for the treatment of pulmonary embolism (PE).

Accordion Pill for proprietary compound achieves in-vitro specifications

Transaction brings together world’s most technologically advanced vaporizer company and world’s leading cannabis company

Lupin Pharma Canada is pleased to announce the approval from Health Canada for ZAXINE® 550 mg (rifaximin) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.

OTC Markets Group Inc. today announced 1933 Industries Inc. (CSE: TGIF; OTCQX: TGIFF), a vertically integrated cannabis company with operations in the United States and Canada, has qualified to trade on the OTCQX® Best Market. 1933 Industries upgraded to OTCQX from the OTCQB® Venture Market.

Marker Therapeutics, Inc. today announced that its President and CEO, Peter L. Hoang, will present a corporate overview at the upcoming Tumor Targeted Lymphocytes Summit on Wednesday, December 12, 2018.

CareCentrix announced today that its unique employee funded “CareCentrix Cares” program has delivered over half a million dollars in charitable help to more than 230 fellow employees in need. In 2015, CareCentrix leadership saw the opportunity to create a charitable vehicle to meet the needs of employees who were going through difficult circumstances.

Grants rights to research, develop and commercialize antibodies generated using the AlivaMab Mouse platform

- Novel gene therapy for patients with treatment-resistant angina who have no remaining treatment options is ready to enter clinical development -

Casma Therapeutics, Inc. today announced an exclusive and nonexclusive license to technology developed at The University of Texas Southwestern Medical Center that will advance the company’s drive to harness the natural cellular processes of autophagy to design powerful new medicines for a broad range of diseases.